Founded in 2016, Guangzhou paili Biotechnology Co., Ltd. is a high-tech enterprise integrating R & D, production and sales. The company is located in the science and technology enterprise accelerator of Guangzhou Development Zone, with a registered capital of 10 million yuan and a plant of more than 3000 square meters, including more than 800 square meters of 100000 class clean workshop and more than 300 square meters of laboratory. It has passed the recognition of high-tech enterprises and the evaluation of contract abiding and trustworthy enterprises in Guangdong Province.

The company has made great efforts to improve the innovation system and carried out product R & D and clinical cooperation with many medical institutions such as Nanfang Hospital of Southern Medical University, Guangdong Hospital of traditional Chinese medicine, General Hospital of Guangzhou Military Region and the First Affiliated Hospital of Guangzhou Medical University. Its leading product "disposable blood rich small plate plasma preparation" is a high-tech / high value-added product with international and national invention patents, As one of the three types of medical devices, it is at the leading level in terms of operation technology and quality among similar international products. At present, it is an irreplaceable treatment method in the treatment of early / medium-term osteoarthritis. At the same time, it has good clinical therapeutic effects in bone and soft tissue repair, tendon and ligament repair, chronic refractory wound treatment, etc. It also has outstanding curative effect in anti-aging fields such as beauty and hair, and has considerable development and broad market prospects.

The company has a special R & D department and laboratory, a complete set of scientific and technological equipment for the development and experiment of platelet rich plasma preparation device, as well as a complete set of R & D, production, commissioning and inspection equipment. The company's R & D and equipment investment account for more than 60% of the total investment.

Since the company moved to the "science and technology enterprise accelerator" in Guangzhou Development Zone at the end of 2017, it has adhered to product innovation, implemented scientific management, improved the quality management system, It has obtained the medical device business enterprise license (GSP) and domestic nmpa registration, and the EU CE has also been pushed to the final stage. It is a "disposable platelet rich plasma preparation device" independently developed in terms of intellectual property rights The product technology has obtained 2 international and national invention patents, 4 utility model patents and 2 design patents. In order to promote the upgrading of products, the most advanced experimental / production equipment from Japan and other foreign countries are introduced, the product production facilities are optimized, the technical transformation is further strengthened and the process level is improved.

 In terms of marketing, "Guangdong zhongkangyi Pharmaceutical Co., Ltd." under "Guangzhou paili Biotechnology Co., Ltd." was formerly known as Guangdong Yingde KANGYI Pharmaceutical Co., Ltd., a state-owned enterprise with a history of more than 60 years. The company was established in 2004 with a registered capital of 10 million yuan. It is a provincial pharmaceutical company mainly engaged in imported drugs and medical devices. The company inherits the business philosophy of "honesty and excellence", pays attention to the high-tech nature of products, and is committed to introducing innovative products at home and abroad Korea (artificial joint), USA (BOCO, Johnson & Johnson), Germany, France (Aikesen) and other well-known foreign enterprises have carried out close cooperation and formed a product supply chain that relies on foreign advanced technology to serve the domestic high-end market. At present, there are ready-made sales channels in China and have entered the stage of exploring foreign markets. The alliance between the two companies can be said to be a strong alliance. The product R & D and manufacturing capacity of Guangzhou paili Biotechnology Co., Ltd. and Guangdong public The marketing channel and marketing support of KANGYI Pharmaceutical Co., Ltd. will have the effect of mutual benefit and complementarity between the two companies and ensure the sound development of the two companies.

The company has always adhered to the values of "integrity, professionalism, pragmatism and innovation", carefully built a professional technical team and continuously improved its R & D / manufacturing capacity. We are committed to developing the world's most high-end platelet rich plasma preparation device and clinical application scheme providing team, and strive to become a world-class leader in the research and development of platelet rich plasma preparation device and clinical application scheme.